Precipio, Inc. (NASDAQ:PRPO – Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $8.35 and traded as low as $8.28. Precipio shares last traded at $8.53, with a volume of 4,732 shares changing hands.
Precipio Trading Up 0.7 %
The business has a 50 day moving average of $6.72 and a two-hundred day moving average of $8.35. The company has a current ratio of 0.92, a quick ratio of 0.81 and a debt-to-equity ratio of 0.01. The firm has a market cap of $11.75 million, a P/E ratio of -0.93 and a beta of 1.89.
Precipio (NASDAQ:PRPO – Get Free Report) last issued its quarterly earnings data on Friday, August 11th. The biotechnology company reported ($1.80) earnings per share for the quarter. The company had revenue of $3.53 million during the quarter. Precipio had a negative net margin of 98.50% and a negative return on equity of 68.59%.
Institutional Inflows and Outflows
Precipio Company Profile
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests.
- Five stocks we like better than Precipio
- Comparing and Trading High PE Ratio Stocks
- These 5 small-cap impact stocks are making social change
- How to Invest in Social Media
- Alphabet slays its earnings but falls on its sword with cloud
- What is Put Option Volume?
- There’s nothing artificial about NVIDIA’s relationship with AI
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.